Long-term Effects of Inhaled Corticosteroids (ICS) Treatment on Sputum Bacterial and Viral Loads in COPD Patients

Trial Profile

Long-term Effects of Inhaled Corticosteroids (ICS) Treatment on Sputum Bacterial and Viral Loads in COPD Patients

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Oct 2017

At a glance

  • Drugs Salmeterol/fluticasone propionate (Primary) ; Salmeterol
  • Indications Chronic obstructive pulmonary disease
  • Focus Pharmacodynamics; Proof of concept
  • Acronyms PROBE
  • Most Recent Events

    • 01 Oct 2017 Results published in the European Respiratory Journal
    • 10 Jun 2017 Biomarkers information updated
    • 01 Jan 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top